A Role for Impaired RECK Activity in Metabolic Dysfunction-associated Steatotic Liver Disease.
作者信息
Finck Brian N
机构信息
Center for Human Nutrition, Division of Nutritional Sciences and Obesity Medicine, Washington University School of Medicine, St Louis, Missouri.
出版信息
Cell Mol Gastroenterol Hepatol. 2024;18(5):101388. doi: 10.1016/j.jcmgh.2024.101388. Epub 2024 Aug 24.
Abstract
摘要
相似文献
1
A Role for Impaired RECK Activity in Metabolic Dysfunction-associated Steatotic Liver Disease.RECK活性受损在代谢功能障碍相关脂肪性肝病中的作用。
Cell Mol Gastroenterol Hepatol. 2024;18(5):101388. doi: 10.1016/j.jcmgh.2024.101388. Epub 2024 Aug 24.
2
Hepatocellular RECK as a Critical Regulator of Metabolic Dysfunction-associated Steatohepatitis Development.肝细胞 REck 作为代谢功能障碍相关脂肪性肝炎发展的关键调节因子。
Cell Mol Gastroenterol Hepatol. 2024;18(3):101365. doi: 10.1016/j.jcmgh.2024.101365. Epub 2024 May 24.
3
Female reproductive factors and metabolic dysfunction-associated steatotic liver disease: an integrated analysis of population cohort, liver imaging, and genetic data.女性生殖因素与代谢功能障碍相关脂肪性肝病：一项基于人群队列、肝脏影像学和基因数据的综合分析
Am J Obstet Gynecol. 2025 Apr 29. doi: 10.1016/j.ajog.2025.04.007.
4
Metabolic dysfunction-associated steatotic liver disease prevalence and risk factors in inflammatory bowel disease in tertiary center.代谢相关脂肪性肝病在三级中心炎症性肠病中的患病率及相关危险因素。
Rev Assoc Med Bras (1992). 2024 Jul 19;70(6):e20231321. doi: 10.1590/1806-9282.20231321. eCollection 2024.
5
Menopause and metabolic dysfunction-associated steatotic liver disease.绝经与代谢功能紊乱相关的脂肪性肝病。
Maturitas. 2024 Aug;186:108024. doi: 10.1016/j.maturitas.2024.108024. Epub 2024 May 14.
6
The therapeutic potential of different mesenchymal stem cells and their derived exosomes in metabolic dysfunction-associated steatotic liver disease.不同间充质干细胞及其衍生外泌体在代谢功能障碍相关脂肪性肝病中的治疗潜力。
Front Endocrinol (Lausanne). 2025 Apr 3;16:1558194. doi: 10.3389/fendo.2025.1558194. eCollection 2025.
7
The association between alcohol consumption and cardiometabolic factors and liver fibrosis in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated liver disease.酒精摄入与代谢功能障碍相关脂肪性肝病和代谢功能障碍及酒精相关肝病中与心血管代谢因素和肝纤维化的关联。
Aliment Pharmacol Ther. 2024 Dec;60(11-12):1587-1598. doi: 10.1111/apt.18280. Epub 2024 Sep 23.
8
A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone.用于检测代谢功能障碍相关脂肪性肝病患者显著纤维化的非侵入性检测组合并不优于单独使用磁共振弹性成像。
Eur Radiol. 2024 Jun;34(6):3882-3888. doi: 10.1007/s00330-023-10441-5. Epub 2023 Nov 21.
9
Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation.早期实验性代谢功能障碍相关脂肪性肝病中的认知功能障碍与全身炎症和神经炎症有关。
JHEP Rep. 2023 Dec 21;6(3):100992. doi: 10.1016/j.jhepr.2023.100992. eCollection 2024 Mar.
10
Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) after Liver Transplantation: A Narrative Review of an Emerging Issue.肝移植后代谢功能障碍相关脂肪性肝病（MASLD）：一个新出现问题的叙述性综述
J Clin Med. 2024 Jun 30;13(13):3871. doi: 10.3390/jcm13133871.
本文引用的文献
1
Prevalence of Steatotic Liver Disease Subtypes and Association With Metabolic Risk Factors in the Framingham Heart Study.脂肪肝疾病亚型的流行情况及其与弗雷明汉心脏研究中代谢危险因素的关系。
Clin Gastroenterol Hepatol. 2024 Nov;22(11):2330-2333. doi: 10.1016/j.cgh.2024.05.030. Epub 2024 Jun 9.
2
Hepatocellular RECK as a Critical Regulator of Metabolic Dysfunction-associated Steatohepatitis Development.肝细胞 REck 作为代谢功能障碍相关脂肪性肝炎发展的关键调节因子。
Cell Mol Gastroenterol Hepatol. 2024;18(3):101365. doi: 10.1016/j.jcmgh.2024.101365. Epub 2024 May 24.
3
Resmetirom's approval: Highlighting the need for comprehensive approaches in NASH therapeutics.雷美替胺获批：凸显 NASH 治疗中全面方法的必要性。
Clin Res Hepatol Gastroenterol. 2024 Aug;48(7):102377. doi: 10.1016/j.clinre.2024.102377. Epub 2024 May 19.
4
A global action agenda for turning the tide on fatty liver disease.全球行动议程：扭转脂肪肝疾病流行趋势。
Hepatology. 2024 Feb 1;79(2):502-523. doi: 10.1097/HEP.0000000000000545. Epub 2023 Aug 4.
5
The Role of RECK in Hepatobiliary Neoplasia Reveals Its Therapeutic Potential in NASH.RECK 在肝胆肿瘤中的作用揭示了其在 NASH 中的治疗潜力。
Front Endocrinol (Lausanne). 2021 Oct 20;12:770740. doi: 10.3389/fendo.2021.770740. eCollection 2021.
6
RECK expression is associated with angiogenesis and immunogenic Tumor Microenvironment in Hepatocellular Carcinoma, and is a prognostic factor for better survival.RECK表达与肝细胞癌的血管生成和免疫原性肿瘤微环境相关，并且是生存预后较好的一个因素。
J Cancer. 2021 May 5;12(13):3827-3840. doi: 10.7150/jca.56167. eCollection 2021.
7
Reversion inducing cysteine rich protein with Kazal motifs and cardiovascular diseases: The RECKlessness of adverse remodeling.富含半胱氨酸的 Kazal 基序的回复诱导蛋白与心血管疾病：不良重构的肆意妄为。
Cell Signal. 2021 Jul;83:109993. doi: 10.1016/j.cellsig.2021.109993. Epub 2021 Mar 27.
8
ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development.内质网应激与营养过剩协同作用触发 TNF 依赖性自发性 HCC 发生。
Cancer Cell. 2014 Sep 8;26(3):331-343. doi: 10.1016/j.ccr.2014.07.001. Epub 2014 Aug 14.
9
RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch.RECK通过调节一种趋同的、依赖STAT3的新生血管生成开关来控制乳腺癌转移。
Oncogene. 2015 Apr 23;34(17):2189-203. doi: 10.1038/onc.2014.175. Epub 2014 Jun 16.
Zotero 插件